Preventing chronic kidney disease in special populations

Area of Science:

• Nephrology
• Cardiology
• Public Health

Background:

• Hypertension is a primary risk factor for chronic kidney disease (CKD), cardiovascular disease, cerebrovascular events, and mortality.
• Certain populations, including diabetic patients, older adults with isolated systolic hypertension, and specific ethnic groups, face elevated risks of hypertensive end-organ damage.
• The combination of diabetes and hypertension markedly increases the likelihood of developing CKD and other target-organ complications.

Purpose of the Study:

• To highlight the increased prevalence of hypertension-related complications in specific at-risk populations.
• To emphasize the potential for preventing or delaying end-stage renal disease (ESRD) and associated cardiovascular events through early risk identification.
• To inform the development of optimal antihypertensive strategies for high-risk individuals.

Main Methods:

• Review of existing literature and clinical data on hypertension and its complications.
• Analysis of risk factors contributing to hypertensive end-organ damage.
• Examination of data from controlled clinical hypertension trials.

Main Results:

• African Americans exhibit a higher prevalence of hypertension, left ventricular hypertrophy, CKD, hypertensive renal disease, and ESRD compared to white Americans.
• Diabetic patients and older individuals with isolated systolic hypertension are at increased risk for hypertensive end-organ damage.
• Coexistent diabetes and hypertension significantly amplify the risk for CKD and other target-organ issues.

Conclusions:

• Identifying patients at high risk for CKD is essential for preventing or delaying ESRD and cardiovascular complications.
• Tailoring antihypertensive regimens based on individual risk factors, such as diabetes and ethnicity, is crucial.
• Clinical hypertension trials provide valuable data for optimizing treatment strategies in at-risk populations.